Detailed View
SLS - SELLAS Life Sciences Group, Inc
Latest filing: 2025-09-30 | Reporting: gaap
Market Cap
912,711,744
Adj EBIT (TTM)
-26,937,000
Enterprise Value
868,391,744
Last Price
5.36
Earnings Yield
-3.10%
Return on Capital
-61.62%
Capital
43,716,000
1Y Price Chart
Last Price: $5.36
1Y Change: 370.18%
As of 2026-03-16 | 1Y Change: 370.18%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2025-09-30 | 10-Q | 2025 | 0 | -7,083,000 |
| 2025-06-30 | 10-Q | 2025 | 0 | -6,873,000 |
| 2025-03-31 | 10-Q | 2025 | 0 | -6,063,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | -6,918,000 |
| 2024-09-30 | 10-Q | 2024 | 0 | -7,329,000 |
| 2024-06-30 | 10-Q | 2024 | 0 | -7,621,000 |
| 2024-03-31 | 10-Q | 2024 | 0 | -9,645,000 |
| 2023-12-31 | 10-K (Q4 derived) | 2023 | 0 | -8,177,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.